Published in Kidney Int on July 01, 2002
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ (2008) 5.14
Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol (2008) 3.26
Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res (2011) 2.56
Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study. Am J Kidney Dis (2011) 2.25
The emerging role of phosphate in vascular calcification. Kidney Int (2009) 2.14
Plasma pyrophosphate and vascular calcification in chronic kidney disease. Nephrol Dial Transplant (2009) 2.02
The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol (2008) 1.99
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant (2010) 1.83
Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet. Kidney Int (2012) 1.82
Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int (2009) 1.77
Value of the new bone classification system in pediatric renal osteodystrophy. Clin J Am Soc Nephrol (2010) 1.75
Con: Phosphate binders in chronic kidney disease. Nephrol Dial Transplant (2015) 1.72
Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Int J Cardiovasc Imaging (2008) 1.67
Cardiovascular effects of sevelamer in stage 3 CKD. J Am Soc Nephrol (2013) 1.66
Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function. Clin J Am Soc Nephrol (2009) 1.62
Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol (2008) 1.62
Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2009) 1.50
Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol (2009) 1.49
Sevelamer hydrochloride: an effective phosphate binder in dialyzed children. Pediatr Nephrol (2003) 1.49
Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results. Clin J Am Soc Nephrol (2008) 1.47
Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis. Clin J Am Soc Nephrol (2011) 1.45
Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol (2010) 1.40
Fetuin-A and kidney function in persons with coronary artery disease--data from the Heart and Soul Study. Nephrol Dial Transplant (2006) 1.34
The role of phosphorus in the development and progression of vascular calcification. Am J Kidney Dis (2011) 1.26
Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients. J Am Soc Nephrol (2008) 1.25
Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. Am J Nephrol (2010) 1.25
The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification. Clin Nephrol (2010) 1.21
Calcification in atherosclerosis. Nat Rev Cardiol (2009) 1.20
CKD-mineral and bone disorder: core curriculum 2011. Am J Kidney Dis (2011) 1.20
Incidence and progression of coronary calcification in chronic kidney disease: the Multi-Ethnic Study of Atherosclerosis. Kidney Int (2009) 1.19
Recent progress in the treatment of vascular calcification. Kidney Int (2010) 1.18
Direct effects of phosphate on vascular cell function. Adv Chronic Kidney Dis (2011) 1.17
Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. Am J Pathol (2011) 1.14
The mechanism of vascular calcification - a systematic review. Med Sci Monit (2012) 1.13
Update and critical appraisal of sevelamer in the management of chronic renal failure. Open Access J Urol (2010) 1.13
Chronic kidney disease mineral and bone disorder in children. Pediatr Nephrol (2007) 1.11
Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis. Pediatr Nephrol (2003) 1.11
Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol (2009) 1.09
Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients. Clin J Am Soc Nephrol (2012) 1.09
Calcific aortic valve disease: a consensus summary from the Alliance of Investigators on Calcific Aortic Valve Disease. Arterioscler Thromb Vasc Biol (2014) 1.07
Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients. Clin J Am Soc Nephrol (2011) 1.06
Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Eur Radiol (2008) 1.06
Vascular calcification: pathophysiology and risk factors. Curr Hypertens Rep (2012) 1.06
Phosphate and cardiovascular disease. Adv Chronic Kidney Dis (2011) 1.06
Dyslipidemia associated with chronic kidney disease. Open Cardiovasc Med J (2011) 1.06
Effects of sevelamer on HbA1c, inflammation, and advanced glycation end products in diabetic kidney disease. Clin J Am Soc Nephrol (2012) 1.05
Pharmacology, efficacy and safety of oral phosphate binders. Nat Rev Nephrol (2011) 1.02
Effect of aggressive risk factor modification on cardiac events and myocardial ischaemia in patients with chronic kidney disease. Heart (2006) 1.01
Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J (2012) 1.00
Magnesium carbonate for phosphate control in patients on hemodialysis. A randomized controlled trial. Int Urol Nephrol (2008) 1.00
The roles of the skeleton and phosphorus in the CKD mineral bone disorder. Adv Chronic Kidney Dis (2011) 1.00
Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis. Kidney Int (2011) 1.00
The demise of calcium-based phosphate binders-is this appropriate for children? Pediatr Nephrol (2014) 0.99
Patient education for phosphorus management in chronic kidney disease. Patient Prefer Adherence (2013) 0.99
Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift? Nat Clin Pract Nephrol (2008) 0.98
Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients. Clin J Am Soc Nephrol (2007) 0.98
Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients. Am J Nephrol (2007) 0.98
Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease. Ther Adv Cardiovasc Dis (2013) 0.96
Renal dysfunction and acceleration of coronary disease. Heart (2004) 0.96
Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate. Ther Clin Risk Manag (2008) 0.96
Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients. BMC Nephrol (2010) 0.95
Progression of aortic arch calcification over 1 year is an independent predictor of mortality in incident peritoneal dialysis patients. PLoS One (2012) 0.95
Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial. Clin J Am Soc Nephrol (2010) 0.95
Peripheral arterial calcification: prevalence, mechanism, detection, and clinical implications. Catheter Cardiovasc Interv (2014) 0.94
Osteo-renal regulation of systemic phosphate metabolism. IUBMB Life (2011) 0.94
Phosphate and vascular calcification: Emerging role of the sodium-dependent phosphate co-transporter PiT-1. Thromb Haemost (2010) 0.94
Mechanisms of arterial calcifications and consequences for cardiovascular function. Kidney Int Suppl (2011) (2013) 0.93
Arterial stiffness. JRSM Cardiovasc Dis (2012) 0.93
Mineral metabolic abnormalities and mortality in dialysis patients. Nutrients (2013) 0.93
Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol (2010) 0.92
Noninvasive imaging for assessment of calcification in chronic kidney disease. Nat Rev Nephrol (2011) 0.91
Mechanisms of the cardiorenal syndromes. Nat Rev Nephrol (2009) 0.91
Phosphate control in dialysis. Int J Nephrol Renovasc Dis (2013) 0.91
Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease. J Clin Endocrinol Metab (2013) 0.91
Arterial calcifications. J Cell Mol Med (2010) 0.90
Impaired muscle strength is associated with fractures in hemodialysis patients. Osteoporos Int (2006) 0.90
Pulse pressure and presence of coronary artery calcification. Clin J Am Soc Nephrol (2009) 0.89
Effects of sevelamer hydrochloride on mortality, lipid abnormality and arterial stiffness in hemodialyzed patients: a propensity-matched observational study. Clin Exp Nephrol (2012) 0.89
FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients. BMC Nephrol (2013) 0.89
Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols. Pediatr Nephrol (2009) 0.89
Progression of coronary calcification in pediatric chronic kidney disease stage 5. Pediatr Nephrol (2008) 0.89
High Parathyroid Hormone Level and Osteoporosis Predict Progression of Coronary Artery Calcification in Patients on Dialysis. J Am Soc Nephrol (2015) 0.89
Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study. Nephrol Dial Transplant (2009) 0.88
A case report of sevelamer-associated recto-sigmoid ulcers. BMC Gastroenterol (2016) 0.88
Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis. J Am Soc Nephrol (2015) 0.87
Cardiorenal Syndrome and the Role of the Bone-Mineral Axis and Anemia. Am J Kidney Dis (2015) 0.87
Dietary L-lysine prevents arterial calcification in adenine-induced uremic rats. J Am Soc Nephrol (2014) 0.86
[Atherosclerosis and uremia: signifance of non-traditional risk factors]. Wien Klin Wochenschr (2003) 0.86
Adynamic bone disease-bone and beyond. NDT Plus (2008) 0.86
Vascular calcification in chronic kidney disease: Pathogenesis and clinical implication. World J Nephrol (2012) 0.86
Carotid artery calcification at the initiation of hemodialysis is a risk factor for cardiovascular events in patients with end-stage renal disease: a cohort study. BMC Nephrol (2011) 0.86
Uraemic vasculopathy in children with chronic kidney disease: prevention or damage limitation? Pediatr Nephrol (2010) 0.85
The effects of vitamin K supplementation and vitamin K antagonists on progression of vascular calcification: ongoing randomized controlled trials. Clin Kidney J (2015) 0.85
The connections between vascular calcification and bone health. Nephrol Dial Transplant (2011) 0.85
All-cause mortality in hemodialysis patients with heart valve calcification. Clin J Am Soc Nephrol (2011) 0.85
Iron-magnesium hydroxycarbonate (fermagate): a novel non-calcium-containing phosphate binder for the treatment of hyperphosphatemia in chronic hemodialysis patients. Clin J Am Soc Nephrol (2009) 0.85
Role of TGF-β in a mouse model of high turnover renal osteodystrophy. J Bone Miner Res (2014) 0.85
Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence. BMC Nephrol (2013) 0.84
Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective. Ther Adv Chronic Dis (2012) 0.84
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61
Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol (2007) 5.91
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis. Lancet (2013) 4.58
Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med (2003) 4.58
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation (2003) 3.94
Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol (2002) 3.83
Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int (2005) 3.71
Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology (2003) 3.70
Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum (2005) 3.17
Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol (2006) 3.10
Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging (2009) 2.86
Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging (2010) 2.48
Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation (2002) 2.47
Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol (2008) 2.32
Sex differences in mental stress-induced myocardial ischemia in young survivors of an acute myocardial infarction. Psychosom Med (2014) 2.12
Coronary aging in HIV-infected patients. Clin Infect Dis (2009) 2.02
High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis (2006) 2.00
Diagnostic performance of fusion of myocardial perfusion imaging (MPI) and computed tomography coronary angiography. J Nucl Cardiol (2009) 1.99
Ethnic differences in the prognostic value of coronary artery calcification for all-cause mortality. J Am Coll Cardiol (2007) 1.99
Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers. Eur Heart J (2006) 1.96
Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults. Ann Epidemiol (2007) 1.84
Vascular calcification in chronic kidney disease. Am J Kidney Dis (2004) 1.81
Epicardial adipose tissue and coronary artery plaque characteristics. Atherosclerosis (2009) 1.77
Heritability and seasonal variability of vitamin D concentrations in male twins. Am J Clin Nutr (2010) 1.73
Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis (2007) 1.73
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients. Am Heart J (2005) 1.72
Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Int J Cardiovasc Imaging (2008) 1.67
Progression of coronary artery calcium in men affected by human immunodeficiency virus infection. Int J Cardiovasc Imaging (2011) 1.63
Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms. Arthritis Rheum (2008) 1.63
Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant (2004) 1.61
Novel solid-state-detector dedicated cardiac camera for fast myocardial perfusion imaging: multicenter comparison with standard dual detector cameras. J Nucl Cardiol (2009) 1.60
Prognostic value of number and site of calcified coronary lesions compared with the total score. JACC Cardiovasc Imaging (2008) 1.57
Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum (2009) 1.56
Effect of intensive versus moderate lipid-lowering therapy on epicardial adipose tissue in hyperlipidemic post-menopausal women: a substudy of the BELLES trial (Beyond Endorsed Lipid Lowering with EBT Scanning). J Am Coll Cardiol (2013) 1.54
Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients. AIDS (2011) 1.53
Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography. Circulation (2002) 1.52
Phosphorus levels are associated with subclinical atherosclerosis in the general population. Atherosclerosis (2008) 1.48
Development of a cardiovascular calcification index using simple imaging tools in haemodialysis patients. Nephrol Dial Transplant (2006) 1.46
Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients. Nephrol Dial Transplant (2010) 1.44
Hybrid myocardial imaging for risk stratification prior to kidney transplantation: added value of coronary calcium and epicardial adipose tissue. J Nucl Cardiol (2013) 1.41
Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke. Am J Epidemiol (2006) 1.36
Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther (2006) 1.31
Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats. Kidney Int (2003) 1.30
Two year comparison of sevelamer and calcium carbonate effects on cardiovascular calcification and bone density. Nephrol Dial Transplant (2005) 1.29
High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol (2002) 1.27
Epicardial adipose tissue volume and coronary artery calcium to predict myocardial ischemia on positron emission tomography-computed tomography studies. J Nucl Cardiol (2010) 1.25
Comparison of prognostic usefulness of coronary artery calcium in men versus women (results from a meta- and pooled analysis estimating all-cause mortality and coronary heart disease death or myocardial infarction). Am J Cardiol (2007) 1.24
Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus. J Rheumatol (2008) 1.24
Coronary artery calcium as a measure of biologic age. Atherosclerosis (2005) 1.24
Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. J Am Coll Cardiol (2005) 1.22
Thoracic aorta calcification detected by electron beam tomography predicts all-cause mortality. Atherosclerosis (2009) 1.22
Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals. Circ Cardiovasc Imaging (2012) 1.22
Calcification in atherosclerosis. Nat Rev Cardiol (2009) 1.20
Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality. Am J Epidemiol (2008) 1.16
Lipodystrophy and anti-retroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects. Atherosclerosis (2009) 1.14
Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis (2008) 1.13
Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Kidney Int (2003) 1.11
Improved long-term survival of dialysis patients after near-total parathyroidectomy. J Am Coll Surg (2012) 1.10
The effects of sevelamer hydrochloride and calcium carbonate on kidney calcification in uremic rats. J Am Soc Nephrol (2002) 1.10
Mortality rates in smokers and nonsmokers in the presence or absence of coronary artery calcification. JACC Cardiovasc Imaging (2012) 1.09
The importance of ventricular-vascular uncoupling. JACC Heart Fail (2014) 1.07
Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging. Eur Radiol (2008) 1.06
Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis. Arthritis Rheum (2008) 1.06
Factors associated with mortality in patients new to haemodialysis. Nephrol Dial Transplant (2007) 1.03
Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis. Arthritis Care Res (Hoboken) (2010) 1.02
Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis. J Rheumatol (2010) 1.02
Calculation of coronary age using calcium scores in multiple ethnicities. Int J Cardiovasc Imaging (2007) 1.01
Association of serum intact parathyroid hormone with lower estimated glomerular filtration rate. Clin J Am Soc Nephrol (2008) 1.01
Presence of valvular calcification predicts the response to cinacalcet: data from the ADVANCE study. J Heart Valve Dis (2013) 1.00
Serum osteoprotegerin is increased and independently associated with coronary-artery atherosclerosis in patients with rheumatoid arthritis. Atherosclerosis (2007) 1.00
A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation. J Vasc Access (2012) 0.98
Atherosclerosis and inflammation: insights from rheumatoid arthritis. Clin Rheumatol (2007) 0.98
Imaging of coronary atherosclerosis by computed tomography. Eur Heart J (2010) 0.98
Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis. J Bone Miner Res (2004) 0.98
Impact of coronary artery calcification on all-cause mortality in individuals with and without hypertension. Atherosclerosis (2012) 0.97
Relation of borderline peripheral arterial disease to cardiovascular disease risk. Am J Cardiol (2006) 0.97
Inflammation is related to coronary flow reserve detected by positron emission tomography in asymptomatic male twins. J Am Coll Cardiol (2011) 0.96
Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum (2010) 0.96
Effects of sevelamer and calcium-based phosphate binders on uric acid concentrations in patients undergoing hemodialysis: a randomized clinical trial. Arthritis Rheum (2005) 0.95
Ectopic fat is linked to prior cardiovascular events in men with HIV. J Acquir Immune Defic Syndr (2012) 0.95
Coronary and aortic calcifications in patients new to dialysis. Hemodial Int (2004) 0.95
Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis. J Rheumatol (2007) 0.94
Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency. Nephrol Dial Transplant (2003) 0.94
Can balloon aortic valvuloplasty help determine appropriate transcatheter aortic valve size? JACC Cardiovasc Interv (2008) 0.94
Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis. Am J Clin Nutr (2012) 0.94
Absorption of colesevelam hydrochloride in healthy volunteers. Ann Pharmacother (2002) 0.93
Tracking atherosclerosis regression: a clinical tool in preventive cardiology. Atherosclerosis (2005) 0.93
Noninvasive imaging for assessment of calcification in chronic kidney disease. Nat Rev Nephrol (2011) 0.91
Difference in atherosclerosis burden in different nations and continents assessed by coronary artery calcium. Atherosclerosis (2005) 0.91
Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arterial remodeling, and microvascular function. J Invasive Cardiol (2012) 0.90
Aspirin therapy and thromboxane biosynthesis in systemic lupus erythematosus. Lupus (2007) 0.89
How long is the warranty period for nil or low coronary artery calcium in patients new to hemodialysis? J Nephrol (2009) 0.89
The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients. Am J Nephrol (2003) 0.89
New insights into ischemic heart disease in women. Cleve Clin J Med (2007) 0.88